Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Riemekasten

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Progress in Systemic Sclerosis - Early, Targeted and Intensive Therapy is the Key to Success]Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|December 19, 2020
[How do I treat interstitial lung disease in systemic sclerosis?]Gabriela Riemekasten
Best Practice & Research. Clinical Rheumatology|March 22, 2021
Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosisMartin Aringer, Gabriela Riemekasten
Current Rheumatology Reports|April 17, 2015
Functional autoantibodies in systemic sclerosis pathogenesisAngela Kill, Gabriela Riemekasten
Der Internist|November 23, 2019
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|August 21, 2003
[Regulatory T cells - a possible promising target in the treatment of autoimmune diseases]Philipp Enghard, Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|August 2, 2024
[Update on systemic sclerosis]Gabriela Riemekasten, Ulf Müller-Ladner
Expert Review of Clinical Immunology|November 13, 2015
Risk factors for severity and manifestations in systemic sclerosis and prediction of disease courseMike O Becker, Gabriela Riemekasten
Autoimmunity Reviews|March 13, 2016
Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosisOtavio Cabral-Marques, Gabriela Riemekasten
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Progress in Systemic Sclerosis - Early, Targeted and Intensive Therapy is the Key to Success]Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|December 19, 2020
[How do I treat interstitial lung disease in systemic sclerosis?]Gabriela Riemekasten
Best Practice & Research. Clinical Rheumatology|March 22, 2021
Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosisMartin Aringer, Gabriela Riemekasten
Current Rheumatology Reports|April 17, 2015
Functional autoantibodies in systemic sclerosis pathogenesisAngela Kill, Gabriela Riemekasten
Der Internist|November 23, 2019
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|August 21, 2003
[Regulatory T cells - a possible promising target in the treatment of autoimmune diseases]Philipp Enghard, Gabriela Riemekasten
Zeitschrift Fur Rheumatologie|August 2, 2024
[Update on systemic sclerosis]Gabriela Riemekasten, Ulf Müller-Ladner
Expert Review of Clinical Immunology|November 13, 2015
Risk factors for severity and manifestations in systemic sclerosis and prediction of disease courseMike O Becker, Gabriela Riemekasten
Autoimmunity Reviews|March 13, 2016
Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosisOtavio Cabral-Marques, Gabriela Riemekasten
Pageof 27